StatSure Diagnostic Systems, Inc. (SSUR)
StatSure Diagnostic Systems, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Brooklyn, NY, US. The stock last traded at $0.00, down 99.60% on the session, giving a market capitalisation of $107,057. Its beta of -1.42 implies it has historically moved less than the broad market.
StatSure Diagnostic Systems, Inc. specializes in the creation, production, and distribution of swift in-vitro diagnostic tests. These assays are utilized for identifying infectious diseases and a range of other health concerns, with their availability spanning both the United States and global markets. Among its key offerings are the SURE CHECK HIV 1/2 and Clearview Complete HIV 1/2 tests, which are singular-use diagnostic tools crafted for the visual detection of antibodies to HIV-1 and HIV-2. The company also supplies equipment for collecting medical specimens. Established in 1986, the firm maintains its headquarters in Brooklyn, New York.
StatSure Diagnostic Systems, Inc. is most often compared with the following Healthcare names: